Engitix Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Research Report On Global NASH Drug Pipeline Market

ANI Pharmaceuticals (NASDAQ:ANIP – Get Rating) and Morphic (NASDAQ:MORF – Get Rating) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, analyst recommendations, institutional ownership, dividends, profitability and risk. Institutional and Insider Ownership 59.7% of ANI Pharmaceuticals shares are […]

Collaboration combines Engitix’s unique human extracellular matrix (ECM) platform with Takeda’s expertise in gastroenterology research and development (R&D) and commercialisationAgreement with Takeda for the discovery and development of novel therapeutics for inflammatory bowel disease (IBD) builds on existing colla...

(Bloomberg) -- U.K.-based biotech firm Engitix Ltd. and Japanese drugmaker Takeda Pharmaceutical Co. have agreed to extend their existing partnership in a deal could be valued at as much as $300 million.

Engitix Announces Expanded Collaboration and Licensing Agreement with Takeda to Develop New Anti-Fibrotic Therapies in Inflammatory Bowel Disease - read this article along with other careers information, tips and advice on BioSpace